Keyphrases
5-year Survival
21%
Adult Comorbidity Evaluation-27
13%
Cancer Patients
19%
Chemotherapy
13%
Chiari Malformation Type I
12%
Chronic Rhinosinusitis
50%
Clinical Severity
27%
Clinical Trials
14%
Comorbidity
100%
Comorbidity Index
16%
Computed Tomography
13%
Confidence Interval
43%
COVID-19
15%
Dural Arteriovenous Fistula (dAVF)
19%
Ecological Momentary Assessment
16%
Functional Connectivity
13%
Functional Endoscopic Sinus Surgery
14%
Head-and-neck
32%
Head-and-neck Cancer
85%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
16%
Hearing Impairment
15%
Hereditary Hemorrhagic Telangiectasia
16%
High-risk Human Papillomavirus (HR-HPV)
17%
Neoadjuvant
12%
Neural Connectivity
12%
Obstructive Sleep Apnea-hypopnea Syndrome (OSAHS)
13%
Odds Ratio
20%
Olfactory Dysfunction
25%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
17%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
27%
Otolaryngology
29%
Outcomes Research
25%
Overall Survival
25%
P16-positive
13%
Patient-centered
13%
Placebo
14%
Quality of Life
15%
Randomized Clinical Trial
35%
Rhinosinusitis
13%
Risk Factors
17%
Severity Staging
30%
Sino-Nasal Outcome Test
18%
Sinusitis
15%
Staging System
50%
Tinnitus
95%
Tinnitus Handicap Inventory
17%
TNM Staging
14%
Treatment Efficacy
15%
Tumor
16%
University of Washington
14%
Medicine and Dentistry
Arnold Chiari Malformation
19%
Cancer
14%
Cancer Staging
17%
Chronic Rhinosinusitis
47%
Clinical Trial
12%
Clinician
11%
Combination Therapy
18%
Comorbidity
96%
Computer Assisted Tomography
14%
COVID-19
23%
Diseases
50%
Dural Arteriovenous Fistula
19%
Functional Endoscopic Sinus Surgery
20%
Hazard Ratio
16%
Head and Neck Cancer
70%
Head and Neck Squamous Cell Carcinoma
12%
Head and Neck Surgery
13%
Hearing Impairment
15%
Hereditary Hemorrhagic Telangiectasia
12%
Larynx
12%
Malignant Neoplasm
63%
Medical Record
11%
Multivariate Analysis
13%
Nasal Polyp
13%
Neck
24%
Neoplasm
35%
Obstructive Sleep Apnea
17%
Odds Ratio
27%
Oral Cavity
11%
Oropharynx Carcinoma
19%
Oropharynx Squamous Cell Carcinoma
16%
Otorhinolaryngology
25%
Overall Survival
28%
P16
17%
Patient-Reported Outcome
13%
Placebo
17%
Quality of Life
31%
Radiation Therapy
13%
Randomized Clinical Trial
32%
Recurrent Disease
20%
Rhinosinusitis
19%
Sinus Surgery
11%
Sinusitis
18%
Spine Surgery
12%
Squamous Cell Carcinoma
19%
Surgery
23%
Survival Rate
16%
Systematic Review
12%
Tinnitus
19%
Wart Virus
19%